Skip to content

Vor Biopharma VOR Accounts Payable

Accounts Payable at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.46B+9.6%
Amgen logo
AmgenAMGN
$2.94B+22.0%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$489.3M+10.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.51M-26.2%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$2.28M-28.4%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$356K-47.7%

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,513%
Enterprise value$617.68M+5,639%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's accounts payable?
Vor Biopharma (VOR) reported accounts payable of $1.04M in Q1 2026.
How has Vor Biopharma's accounts payable changed year-over-year?
Vor Biopharma's accounts payable decreased by 72.1% year-over-year, from $3.73M to $1.04M.
What is the long-term trend for Vor Biopharma's accounts payable?
Over 5 years (2020 to 2025), Vor Biopharma's accounts payable has grown at a 16.8% compound annual growth rate (CAGR), from $2.36M to $5.13M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.